loading

Brainstorm Cell Therapeutics Inc (BCLI) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Research and Development
43.40%
0.961
1.698 3.33 2.794 2.924
Operating Income/Loss
48.50%
-2.474
-4.804 -6.035 -5.449 -5.151
Income/Loss From Continuing Operations Before Tax
39.03%
-3.401
-5.578 -1.226 -5.329 -5.059
Income/Loss From Continuing Operations After Tax
39.03%
-3.401
-5.578 -1.226 -5.329 -5.059
Net Income/Loss
39.03%
-3.401
-5.578 -1.226 -5.329 -5.059
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,195%
64.74
2.8204 44.25 39.70 36.74
Diluted Average Shares
2,195%
64.74
2.8204 44.25 39.70 36.74
Basic Earnings Per Share
54.55%
-0.05
-0.11 -0.03 -0.13 -0.14
Diluted Earnings Per Share
54.55%
-0.05
-0.11 -0.03 -0.13 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):